Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

BILE ACID TRANSPORT

Identifieur interne : 00AC02 ( Main/Exploration ); précédent : 00AC01; suivant : 00AC03

BILE ACID TRANSPORT

Auteurs : Ron Jonathan Bahar ; Andrew Stolz [États-Unis]

Source :

RBID : ISTEX:D2077A938BD46D1ACC5923F039CD2EC0ACF569D3

Abstract

Bile acids are end products of cholesterol and play essential roles in a number of diverse physiologic functions.73 They are the major driving force for bile formation, are required to form micelles with fatty acids and other intraluminal hydrophobic compounds that are necessary for their uptake by enterocytes, and are the major excretory products of cholesterol. To conserve the high metabolic cost of bile acid synthesis, the bile acid pool is recirculated up to 10 to 20 times each day in a unique enterohepatic circulation.34,73 This process allows for bile acids to be reabsorbed from their site of action in the intestinal lumen and return to the liver by way of the portal vascular system. This article summarizes current understanding of how the different components that constitute this remarkably efficient system operate and highlights advances in the molecular identification of these specific bile acid transporters. Advances in understanding of how mutations of these bile acid transporters lead to distinct clinical entities, which predominately present as familial intrahepatic cholestatic syndromes, are also summarized. Use of these bile acid transporters for enhanced intestinal absorption of drugs or targeting to the liver is also briefly reviewed.

Url:
DOI: 10.1016/S0889-8553(05)70042-X


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>BILE ACID TRANSPORT</title>
<author>
<name sortKey="Bahar, Ron Jonathan" sort="Bahar, Ron Jonathan" uniqKey="Bahar R" first="Ron Jonathan" last="Bahar">Ron Jonathan Bahar</name>
</author>
<author>
<name sortKey="Stolz, Andrew" sort="Stolz, Andrew" uniqKey="Stolz A" first="Andrew" last="Stolz">Andrew Stolz</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D2077A938BD46D1ACC5923F039CD2EC0ACF569D3</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0889-8553(05)70042-X</idno>
<idno type="url">https://api.istex.fr/document/D2077A938BD46D1ACC5923F039CD2EC0ACF569D3/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006259</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006259</idno>
<idno type="wicri:Area/Istex/Curation">006259</idno>
<idno type="wicri:Area/Istex/Checkpoint">003519</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003519</idno>
<idno type="wicri:doubleKey">0889-8553:1999:Bahar R:bile:acid:transport</idno>
<idno type="wicri:Area/Main/Merge">00B220</idno>
<idno type="wicri:Area/Main/Curation">00AC02</idno>
<idno type="wicri:Area/Main/Exploration">00AC02</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">BILE ACID TRANSPORT</title>
<author>
<name sortKey="Bahar, Ron Jonathan" sort="Bahar, Ron Jonathan" uniqKey="Bahar R" first="Ron Jonathan" last="Bahar">Ron Jonathan Bahar</name>
<affiliation>
<wicri:noCountry code="subField">(RJB)</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Stolz, Andrew" sort="Stolz, Andrew" uniqKey="Stolz A" first="Andrew" last="Stolz">Andrew Stolz</name>
<affiliation wicri:level="2">
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Medicine, Division of Gastrointestinal and Liver Disease, University of Southern California (AS), Los Angeles</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Gastroenterology Clinics of North America</title>
<title level="j" type="abbrev">GTC</title>
<idno type="ISSN">0889-8553</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1999">1999</date>
<biblScope unit="volume">28</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="27">27</biblScope>
<biblScope unit="page" to="58">58</biblScope>
</imprint>
<idno type="ISSN">0889-8553</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0889-8553</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Bile acids are end products of cholesterol and play essential roles in a number of diverse physiologic functions.73 They are the major driving force for bile formation, are required to form micelles with fatty acids and other intraluminal hydrophobic compounds that are necessary for their uptake by enterocytes, and are the major excretory products of cholesterol. To conserve the high metabolic cost of bile acid synthesis, the bile acid pool is recirculated up to 10 to 20 times each day in a unique enterohepatic circulation.34,73 This process allows for bile acids to be reabsorbed from their site of action in the intestinal lumen and return to the liver by way of the portal vascular system. This article summarizes current understanding of how the different components that constitute this remarkably efficient system operate and highlights advances in the molecular identification of these specific bile acid transporters. Advances in understanding of how mutations of these bile acid transporters lead to distinct clinical entities, which predominately present as familial intrahepatic cholestatic syndromes, are also summarized. Use of these bile acid transporters for enhanced intestinal absorption of drugs or targeting to the liver is also briefly reviewed.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Bahar, Ron Jonathan" sort="Bahar, Ron Jonathan" uniqKey="Bahar R" first="Ron Jonathan" last="Bahar">Ron Jonathan Bahar</name>
</noCountry>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Stolz, Andrew" sort="Stolz, Andrew" uniqKey="Stolz A" first="Andrew" last="Stolz">Andrew Stolz</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00AC02 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00AC02 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D2077A938BD46D1ACC5923F039CD2EC0ACF569D3
   |texte=   BILE ACID TRANSPORT
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024